Business Standard

Cipla Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requir...Read More20/12/2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations ...Read More05/12/2024
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requi...Read More02/12/2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substan...Read More02/12/2024
Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requi...Read More30/11/2024
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requi...Read More28/11/2024
Disclosure Under Regulation 30(5) Of The SEBI (LODR) Regulations 2015 Disclosure under regulation 30(5) of the SEBI (LODR) Regulations 201518/11/2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Req...Read More15/11/2024
USFDA Inspection At Companys Manufacturing Facility In Virgonagar Bengaluru India USFDA inspection at Companys manufacturing facility in Virgonagar Bengaluru Indi...Read More13/11/2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript We are enclosing herewith copy of the transcript of the Companys Q2FY25 earnings...Read More02/11/2024
Update On USFDA Inspection At Companys Manufacturing Facility In Goa India Update on USFDA inspection at Companys manufacturing facility in Goa India30/10/2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Pursuant to Regulation 30(6) of the SEBI 9Listing Obligations and Disclosure) Re...Read More29/10/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Please find the attached newspaper publication29/10/2024
Board Meeting Outcome for Outcome Of Board Meeting Dated 29Th October 2024 Outcome of Board meeting dated 29th October 202429/10/2024
Announcement under Regulation 30 (LODR)-Investor Presentation Please find the attached investor presentation dated 29th October 202429/10/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Please find the attached press release dated 29th October 202429/10/2024
Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended 30Th September 2024 Unaudited financial results (standalone and consolidated) for the quarter and ha...Read More29/10/2024
Announcement under Regulation 30 (LODR)-Updates on Acquisition Update on acquisition of additional equity interest in Cipla (Jiangsu) Pharmaceu...Read More25/10/2024
Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations 2015) Intimation under Regulation 30 of the Securities and Exchange Board of India (Li...Read More17/10/2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot Result of the Postal Ballot along with Scrutiniser report14/10/2024

Load more